| Dr Harrison Clay Carter, MD | |
|
1126 W 12th St, Alma, GA 31510-1814 | |
| (912) 632-7300 | |
| (912) 632-1326 |
| Full Name | Dr Harrison Clay Carter |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 26 Years |
| Location | 1126 W 12th St, Alma, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043221492 | NPI | - | NPPES |
| 000922908B | Medicaid | GA | |
| 000922908A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 050575 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Waycross, GA | Home health agency |
| Altamaha Homecare, Inc | Baxley, GA | Home health agency |
| Chsga Home Health | Vidalia, GA | Home health agency |
| Amedisys Home Health | Vidalia, GA | Home health agency |
| Ware Visiting Nurses Service, Inc | Waycross, GA | Home health agency |
| Bethany Hospice And Palliative Care | Valdosta, GA | Hospice |
| Bacon County Hospital | Alma, GA | Hospital |
| Appling Hospital | Baxley, GA | Hospital |
| Coffee Regional Medical Center, Inc | Douglas, GA | Hospital |
| Jeff Davis Hospital | Hazlehurst, GA | Hospital |
| Memorial University Medical Center | Savannah, GA | Hospital |
| Twin Oaks Convalescent Center | Alma, GA | Nursing home |
| Entity Name | Harrison C Carter Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619174091 PECOS PAC ID: 9335529270 Enrollment ID: O20220708002263 |
News Archive
The number of patients suffering from chronic kidney disease or loss of kidney function is increasing worldwide and with it the number of people who need renal replacement therapy.
Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
With people living longer and leading more-active lives, demands placed on medical equipment have grown. The medical wearable electronics market has evolved to provide patients with a more comfortable experience, while enabling them to be mobile and limit time spent in the hospital for treatment and maintenance.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harrison Clay Carter, MD 1126 W 12th St, Alma, GA 31510-1814 Ph: (912) 632-7300 | Dr Harrison Clay Carter, MD 1126 W 12th St, Alma, GA 31510-1814 Ph: (912) 632-7300 |
News Archive
The number of patients suffering from chronic kidney disease or loss of kidney function is increasing worldwide and with it the number of people who need renal replacement therapy.
Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
A team of Spanish scientists has developed an intelligent nanodevice that lays the foundations for the future development of new therapies against aging. The device consists of nanoparticles that can selectively release drugs in aged human cells.
With people living longer and leading more-active lives, demands placed on medical equipment have grown. The medical wearable electronics market has evolved to provide patients with a more comfortable experience, while enabling them to be mobile and limit time spent in the hospital for treatment and maintenance.
› Verified 3 days ago
Dr. Pitchamuthu Solomon Ramanujeyam, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 207 S Wayne St, Alma, GA 31510 Phone: 912-632-7051 Fax: 912-632-6478 | |
Dr. Neha Kakkar, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 204 E 15th St, Alma, GA 31510 Phone: 912-632-2952 Fax: 912-632-8682 |